Traditional directed evolution has transformed protein engineering by enabling iterative optimization through mutation and experimental screening. However, exploring the enormous protein sequence space using laboratory methods alone is often time-consuming, resource-intensive, and limited by practical screening capacity.
Neoncorte Bio combines artificial intelligence, protein language models, and computational protein engineering to perform in-silico directed evolution, helping research teams prioritize the most promising variants before laboratory validation.
Our AI-assisted workflows accelerate Design-Build-Test-Learn (DBTL) cycles by reducing unnecessary experimental screening while improving the probability of identifying high-performing protein variants.
In-silico directed evolution applies computational models to simulate and prioritize evolutionary pathways before experimental testing.